Cannabis Science’s (OTCPK:CBIS) European subsidiary has purchased a 75% stake in a German biotech called Jinvator, a company developing an ultra-sensitive, rapid HIV/AIDS test called nanoGold.
The test uses what it calls ‘nanoparticle technology’ to detect early-stage HIV.
The goal of this acquisition is to bring nanoGold to the market as quickly as possible.
